Home/Filings/4/0001209191-21-002411
4//SEC Filing

Kent Jeff 4

Accession 0001209191-21-002411

CIK 0001492426other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 9:06 PM ET

Size

17.4 KB

Accession

0001209191-21-002411

Insider Transaction Report

Form 4
Period: 2021-01-04
Kent Jeff
See remarks
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-01-05+24,54975,598 total
  • Award

    Ordinary Shares

    2021-01-05+6,82282,420 total
  • Tax Payment

    Ordinary Shares

    2021-01-05$73.28/sh13,997$1,025,70068,423 total
  • Award

    Restricted Stock Units (RSU)

    2021-01-04+20,95720,957 total
    Ordinary Shares (20,957 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-01-056,7000 total
    Ordinary Shares (6,700 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-01-059,67519,352 total
    Ordinary Shares (9,675 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-01-058,1748,174 total
    Ordinary Shares (8,174 underlying)
Footnotes (5)
  • [F1]Each RSU represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2021, the PSUs vested as to the number of shares reported above.
  • [F3]The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
  • [F4]The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.
  • [F5]The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001769107

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:06 PM ET
Size
17.4 KB